- Home
- FBRX vs TEAF Comparison
FBRX vs TEAF Comparison
Compare FBRX & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- TEAF
- Stock Information
- Founded
- FBRX N/A
- TEAF 2017
- Country
- FBRX United States
- TEAF United States
- Employees
- FBRX N/A
- TEAF N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- FBRX Health Care
- TEAF Finance
- Exchange
- FBRX Nasdaq
- TEAF Nasdaq
- Market Cap
- FBRX 154.5M
- TEAF 158.9M
- IPO Year
- FBRX N/A
- TEAF N/A
- Fundamental
- Price
- FBRX $12.94
- TEAF $12.41
- Analyst Decision
- FBRX Strong Buy
- TEAF
- Analyst Count
- FBRX 3
- TEAF 0
- Target Price
- FBRX $68.00
- TEAF N/A
- AVG Volume (30 Days)
- FBRX 94.9K
- TEAF 56.1K
- Earning Date
- FBRX 11-13-2025
- TEAF 01-01-0001
- Dividend Yield
- FBRX N/A
- TEAF 9.20%
- EPS Growth
- FBRX N/A
- TEAF N/A
- EPS
- FBRX N/A
- TEAF N/A
- Revenue
- FBRX N/A
- TEAF N/A
- Revenue This Year
- FBRX N/A
- TEAF N/A
- Revenue Next Year
- FBRX N/A
- TEAF N/A
- P/E Ratio
- FBRX N/A
- TEAF N/A
- Revenue Growth
- FBRX N/A
- TEAF N/A
- 52 Week Low
- FBRX $4.11
- TEAF $11.11
- 52 Week High
- FBRX $28.68
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- FBRX 49.05
- TEAF 72.70
- Support Level
- FBRX $11.00
- TEAF $12.15
- Resistance Level
- FBRX $15.01
- TEAF $12.16
- Average True Range (ATR)
- FBRX 1.15
- TEAF 0.13
- MACD
- FBRX 0.01
- TEAF 0.05
- Stochastic Oscillator
- FBRX 48.82
- TEAF 99.50
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Sustainable and Social Impact Term Fund Formerly Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.